click below
click below
Normal Size Small Size show me how
ENDOCRINE 1
Drug quiz Benchmark
| Question | Answer |
|---|---|
| What is the brand for metformin (PO) | Glucophage, Glucophage XR |
| What is the brand for saxagliptin (PO) | Onglyza |
| What is the brand for sitagliptin (PO) | Januvia |
| What is the brand for liraglutide (subcutaneous) | Victoza, Saxenda |
| What is the brand for insulin NPH (subcutaneous) | Humulin N, Novolin N |
| What is the brand for insulin detemir (subcutaneous) | Levemir |
| What is the brand for insulin glargine (subcutaneous) | Lantus, Toujeo |
| What is the brand for insulin aspart (subcutaneous) | Novolog |
| What is the brand for insulin lispro (subcutaneous) | Humalog |
| What is the brand for insulin regular (subcutaneous, IV) | Humulin R, Novolin R |
| What is the brand for glimepiride (PO) | Amaryl |
| What is the brand for glipizide (PO) | Glucotrol, Glucotrol XL |
| What is the brand for glyburide (PO) | Glynase |
| What is the brand for pioglitazone (PO) | Actos |
| What is the brand for levothyroxine (PO, IV) | Synthroid, Levoxyl |
| What is the brand for thyroid, dessicated (PO) | Armour Thyroid |
| What is the brand for sitagliptin and metformin (PO) | Janumet, Janumet XR |
| What is the pharmacology category for metformin (PO) | Biguanide |
| What is the pharmacology category for saxagliptin (PO) | Dipeptidyl peptidase (DPP-4) inhibitor |
| What is the pharmacology category for sitagliptin (PO) | Dipeptidyl peptidase (DPP-4) inhibitor |
| What is the pharmacology category for liraglutide (subcutaneous) | Glucagon-like peptide-1 (GLP-1) receptor agonist |
| What is the pharmacology category for insulin NPH (subcutaneous) | Insulin, intermediate acting |
| What is the pharmacology category for insulin detemir (subcutaneous) | Insulin, long acting |
| What is the pharmacology category for insulin glargine (subcutaneous) | Insulin, long acting |
| What is the pharmacology category for insulin aspart (subcutaneous) | Insulin, rapid acting |
| What is the pharmacology category for insulin lispro (subcutaneous) | Insulin, rapid acting |
| What is the pharmacology category for insulin regular (subcutaneous, IV) | Insulin, short-acting |
| What is the pharmacology category for glimepiride (PO) | Sulfonylurea |
| What is the pharmacology category for glipizide (PO) | Sulfonylurea |
| What is the pharmacology category for glyburide (PO) | Sulfonylurea |
| What is the pharmacology category for pioglitazone (PO) | Thiazolidinedione (TZD) |
| What is the pharmacology category for levothyroxine (PO, IV) | Thyroid product |
| What is the common indication for metformin (PO) | Type 2 DM, PCOS |
| What is the common indication for saxagliptin (PO) | Type 2 DM |
| What is the common indication for sitagliptin (PO) | Type 2 DM |
| What is the common indication for liraglutide (subcutaneous) | Type 2 DM, chronic weight management |
| What is the common indication for insulin NPH (subcutaneous) | Type 1 DM, type 2 DM |
| What is the common indication for insulin detemir (subcutaneous) | Type 1 DM, type 2 DM |
| What is the common indication for insulin glargine (subcutaneous) | Type 1 DM, type 2 DM |
| What is the common indication for insulin aspart (subcutaneous) | Type 1 DM, type 2 DM |
| What is the common indication for insulin lispro (subcutaneous) | Type 1 DM, type 2 DM |
| What is the common indication for insulin regular (subcutaneous, IV) | Type 1 DM, type 2 DM, DKA |
| What is the common indication for glimepiride (PO) | Type 2 DM |
| What is the common indication for glipizide (PO) | Type 2 DM |
| What is the common indication for glyburide (PO) | Type 2 DM |
| What is the common indication for pioglitazone (PO) | Type 2 DM |
| What is the common indication for levothyroxine (PO, IV) | Hypothyroidism |
| What is the common indication for thyroid, dessicated (PO) | Hypothyroidism |
| What is the common indication for sitagliptin and metformin (PO) | none |
| What is the Pharmacology category for thyroid, dessicated (PO) | Thyroid product |
| What is the Pharmacology category for sitagliptin and metformin (PO) | none |